OTCM
SONX
Market cap547kUSD
Oct 07, Last price
1.28USD
1D
28.00%
1Q
113.33%
IPO
-86.94%
Name
Sonendo Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sonendo, Inc. operates as a commercial-stage medical technology firm, dedicated to innovating, producing, and marketing advanced devices for root canal treatment across the United States and Canada. A flagship offering is GentleWave, an innovative device for addressing tooth decay that meticulously cleans and sanitizes the intricate microscopic passages within teeth without the need for removing any natural tooth structure. The company's product line also features SoundSeal, a specialized material used to construct and seal dental crowns, alongside its proprietary Sonendo-branded liquid solution of EDTA, which assists in the debridement and disinfection processes crucial for root canal systems. Furthermore, Sonendo provides "The Digital Office," a comprehensive practice management software solution designed to foster an integrated digital environment for dental professionals. Established in 2006, the organization was initially known as Dentatek Corporation before officially rebranding to Sonendo, Inc. in March 2011. Its corporate headquarters are situated in Laguna Hills, California.
Key people
Bjarne Bergheim
President, Chief Executive Officer, Director · since 2017
Michael Watts
Chief Financial Officer
Bob Guyatt
Vice President - Marketing
Roy Chen
Chief Talent Officer
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||